No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals - PubMed (original) (raw)
Randomized Controlled Trial
. 2009 Nov;63(11):1353-9.
doi: 10.1038/ejcn.2009.63. Epub 2009 Jul 22.
Affiliations
- PMID: 19623203
- DOI: 10.1038/ejcn.2009.63
Randomized Controlled Trial
No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals
G K Pot et al. Eur J Clin Nutr. 2009 Nov.
Abstract
Background: A high intake of n-3 polyunsaturated fatty acids (PUFAs), mainly present in fish, may be associated with decreased inflammation. Previous intervention studies on fish PUFA and inflammatory markers in healthy individuals did not analyze a broad spectrum of inflammatory cytokines, chemokines and cell adhesion molecules, or their interrelationships. Therefore, we determined the effects of fish oil supplementation on 19 serum inflammatory markers and their interrelationships in healthy, middle-aged individuals.
Methods: Individuals (n=77) aged 50-70 years completed a randomized, double-blind placebo-controlled intervention study. Participants received 3.5 g/day fish oil (1.5 g/day total n-3 PUFA) (n=39) or placebo (high oleic sunflower oil) (n=38) for 12 weeks. Serum concentrations of 19 inflammatory markers were determined using a multiplex immunoassay before and after intervention. Changes in concentrations were analyzed using analysis of covariance and differences in patterns in inflammatory markers between the fish oil and placebo group were analyzed by principal component analysis.
Results: Fish oil supplementation did not significantly affect serum concentrations of cytokines, chemokines or cell adhesion molecules as compared with placebo. However, there was a trend for all inflammatory markers to increase after fish oil supplementation. PCA did not result in markedly distinctive patterns of inflammatory markers for the fish oil and placebo group.
Conclusion: In conclusion, this 12-week randomized, double-blind placebo-controlled intervention trial did not show that 1.5 g/day n-3 PUFA significantly affected the serum inflammatory response in healthy individuals, nor did patterns of inflammatory markers. Thus, a healthy middle-aged population may not benefit from fish oil as an anti-inflammatory agent.
Similar articles
- Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
Berstad P, Seljeflot I, Veierød MB, Hjerkinn EM, Arnesen H, Pedersen JI. Berstad P, et al. Clin Sci (Lond). 2003 Jul;105(1):13-20. doi: 10.1042/CS20020349. Clin Sci (Lond). 2003. PMID: 12589702 Clinical Trial. - Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo.
Murphy KJ, Galvin K, Kiely M, Morrissey PA, Mann NJ, Sinclair AJ. Murphy KJ, et al. Asia Pac J Clin Nutr. 2006;15(3):418-24. Asia Pac J Clin Nutr. 2006. PMID: 16837436 Clinical Trial. - Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Dunstan JA, et al. J Allergy Clin Immunol. 2003 Dec;112(6):1178-84. doi: 10.1016/j.jaci.2003.09.009. J Allergy Clin Immunol. 2003. PMID: 14657879 Clinical Trial. - A meta-analysis of n-3 polyunsaturated fatty acids effects on circulating acute-phase protein and cytokines in gastric cancer.
Mocellin MC, Fernandes R, Chagas TR, Trindade EBSM. Mocellin MC, et al. Clin Nutr. 2018 Jun;37(3):840-850. doi: 10.1016/j.clnu.2017.05.008. Epub 2017 May 13. Clin Nutr. 2018. PMID: 28666598 - Enteral omega-3 in acute respiratory distress syndrome.
Singer P, Shapiro H. Singer P, et al. Curr Opin Clin Nutr Metab Care. 2009 Mar;12(2):123-8. doi: 10.1097/MCO.0b013e328322e70f. Curr Opin Clin Nutr Metab Care. 2009. PMID: 19202383 Review.
Cited by
- Effects of oral eicosapentaenoic acid versus docosahexaenoic acid on human peripheral blood mononuclear cell gene expression.
Tsunoda F, Lamon-Fava S, Asztalos BF, Iyer LK, Richardson K, Schaefer EJ. Tsunoda F, et al. Atherosclerosis. 2015 Aug;241(2):400-8. doi: 10.1016/j.atherosclerosis.2015.05.015. Epub 2015 May 19. Atherosclerosis. 2015. PMID: 26074314 Free PMC article. Clinical Trial. - An Oily Fish Diet Improves Subclinical Inflammation in People at High Cardiovascular Risk: A Randomized Controlled Study.
Costabile G, Della Pepa G, Vetrani C, Vitaglione P, Griffo E, Giacco R, Vitale M, Salamone D, Rivellese AA, Annuzzi G, Bozzetto L. Costabile G, et al. Molecules. 2021 Jun 2;26(11):3369. doi: 10.3390/molecules26113369. Molecules. 2021. PMID: 34199645 Free PMC article. Clinical Trial. - Mechanistic insights into the health benefits of fish-oil supplementation against fine particulate matter air pollution: a randomized controlled trial.
Zhou L, Jiang Y, Lin Z, Chen R, Niu Y, Kan H. Zhou L, et al. Environ Health. 2022 Oct 29;21(1):104. doi: 10.1186/s12940-022-00908-1. Environ Health. 2022. PMID: 36309727 Free PMC article. Clinical Trial. - Omega-3 Polyunsaturated Fatty Acids And Adipose Tissue Inflammation: Longitudinal Analysis in the PROMISE Cohort.
Chon JE, Semnani-Azad Z, Lai KZH, Connelly PW, Retnakaran R, Harris SB, Metherel AH, Jenkins DJA, Bazinet RP, Hanley AJ. Chon JE, et al. J Clin Endocrinol Metab. 2025 Apr 22;110(5):1324-1333. doi: 10.1210/clinem/dgae445. J Clin Endocrinol Metab. 2025. PMID: 38943663 Free PMC article. - Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease.
Kim OY, Lee SM, An WS. Kim OY, et al. Nutrients. 2018 Oct 7;10(10):1454. doi: 10.3390/nu10101454. Nutrients. 2018. PMID: 30301276 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources